
Five fruits wey dey rich in proteins
Wen pipo see passion fruit, dem tink say e get protein. But dis Caribbean fruit wey some dey call parchita or chinola for di region get valuable nutrients like vitamins, minerals, antioxidants and most importantly fibre and go fit be one of di most useful and unnoticed tools wen e come to building muscle mass.
"Pipo dey surprised to find out say some fruits get more dan 4g of protein in reasonable portion" na so Andrea Delgado tok. She be nutritionist for Mayo Clinic for United States.
"Di key dey often for di seeds" na wetin she tok.
She say though nutrients dey important for our diets, Dr Delgado dey remind us say "body also need fibre, carbohydrates and healthy fats".
She tell BBC Mundo say to include all diz fruits "fit make all di difference" to help build muscle mass.
Here are the fruits the nutritionist reminds us to add to our diet wen we dey try increase our protein intake to rebuild our muscles we use dem finish.
1. Passion fruit (parchita, chinola)
For Delgado, na passion fruit dey top di list wit almost 5g of protein per cup.
Di secret dey for density of di seeds: each seed get concentrates amino acids wey fit comot if dem drive di pulp.
Dis na why she dey recommend make pipo dey eat di whole fruit, and if you dey drink am in juice form no strain di seeds.
"If you strain di seeds, all you go get na di sugar; blend di whole fruit and drink di seeds", na wetin she recommend.
As e contain protein, passion fruit also contain soluble fibre, magnesium and phenolic compounds wey dey help to regulate blood pressure.
2. Guava
Next on di list, Dr. Delgado recommend guava.
She tell BBC Mundo say dis tropical fruit dey provide 4g of protein per cup and dey double di daily recommended amount of vitamin C. Most of di protein dey come from di seeds.
"Most of di protein dey come from di seed, dis na why ground pulp dey prefered to clarified juice". Na so she explain.
E dey reach in anti-inflammatory carotenoids, guava dey promote muscle recovery and also play role of antioxidant, dey prevent di effects of aging.
One portion dey provide more dan 300% of vitamin C requirements, wey dey useful for collagen synthesis and immune function.
According to Delgado, if you crush guava wit plain yogurt, e dey preserve di fruits pits and proteins and also add calcium and probiotics, wey be key elements of nutrition.
3. Pomegranate
For Delgado, pomegranate na excellent choice sake of di amount of nutrients e dey add to di diet.
Di pomegranate reddish arils dey offer 4g of protein per cup and a load of polyphenols wey di Mayo Clinic say dey associated with cardiovascular health and antioxidant action.
Studies wey di clinic do suggest say pomegranate juice fit help maintain healthy blood pressure and cholesterol levels.
Di fibre wey dey inside di seed dey aid digestion and prolong satiety, while di ruby color dey indicate di presence of anthocyanins, anti-inflammatory compounds wey dey linked to cardiovascular and nervous health
Anoda tin be say di versatility of di flavors make am an ideal nutritious accompaniment to all kinds of desserts and salad.
4. Jacquier - jackfruit
For her list, Delgado mention two fruits wey dey go through some form of cooking before eating wen we dey do exercise.
She explain say for vegan cooking, dem dey use dried jackfruit as substitute for meat, say dem dey serve am boiled, sautéed or baked.
According to her, di fruit dey provide up to 2.5g of protein per serving, along with minerals such as potassium and magnesium wey dey essential for healthy bones.
She add say most of di fibre and protein dey dey retained after cooking.
5. Dried apricots
Dried apricots wey dem dey also call apricot pits dey concentrate nutrients and provide up to 4g of protein per cup.
However, Delgado dey emphasize dia practicality: "dem dey light and Dey offer more protein dan wetin you fit get for our commercial bars.
What about avocado?
Wen I begin write dia article, I been tink say Delgado go begin tok about avocado, so I dey surprised say she no even include am for her list.
"Compared to oda nuts and dried fruits, avocados dey provide less protein", na so Delgado explain. "Di main value dey for monounsaturated fats, no be for protein profile. E get protein but very small quantity: around 1.8 grams per cup.
According to di nutritionist, to maintain an adequate protein intake, person wey dey weigh 65 kg supposed to consume between 1 and 1.2g of protein per kilo of weight( data 65 and 78g of protein per day).
"One cup of passion fruit contain 5g of protein, e sound like e no dey enough, but dat one count. Passion fruit contain vitamins, fibre and antioxidants wey supplements no fit provide" na so Delgado tok
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
35 minutes ago
- The Guardian
Key takeaways from world's largest cancer conference in Chicago
Doctors, scientists and researchers shared new findings on ways to tackle cancer at the 2025 American Society of Clinical Oncology annual meeting, the world's largest cancer conference. The event in Chicago, attended by about 44,000 health professionals, featured more than 200 sessions on this year's theme, Driving Knowledge to Action: Building a Better Future. Here is a roundup of the key studies. An immunotherapy drug could help some cancer patients live years longer without the disease getting worse or coming back, a trial found. Pembrolizumab, sold under the brand name Keytruda, kept head and neck cancers at bay for five years, compared to 30 months with standard care. It also cut the risk of the disease returning in another part of the body. A second study showed people with a deadly form of skin cancer could live longer with an innovative one-time immunotherapy. Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, with tumours shrinking in the majority of cases, the trial found. Car T-cell therapy is a new form of immunotherapy where a patient's own T-cells – a type of white blood cell – are tweaked in a lab to target and kill cancer cells. The designer cells are then infused back into their bloodstream to fight the disease. One trial found cancer patients treated by Car T-cell therapy can live 40% longer. The therapy has already proved successful in treating blood cancers. Now results from the world's first randomised controlled trial of Car T-cell therapy in solid tumours suggest it could be transformative in the fight against these cancers too. Solid tumours represent about 90% of all cancers, including breast, lung and pancreatic cancer. In the trial hailed as a 'milestone' by experts, patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer treated with Car T-cell therapy lived on average about 40% longer than patients who received standard care. A second Car T-cell therapy shrank tumours in 62% of patients with recurrent glioblastoma, a rare event for a fatal brain cancer with few treatment options, researchers reported in Chicago. 'Seeing recurrent [glioblastoma] tumours shrink like this is extraordinary, because the immunotherapy drugs that we've tried in the past have been unable to do that,' said the study's lead author, Dr Stephen Bagley, of the University of Pennsylvania. In a world first, doctors announced at the conference that thousands of cancer patients in England would benefit from a DNA blood test that saves lives by fast-tracking them on to personalised treatments. The liquid biopsy looks for circulating tumour DNA (ctDNA) to find specific genetic variations of cancer. The NHS will offer it to patients with lung and breast cancer – two of the most common forms of the disease. Rapid results mean patients can immediately be offered drugs and treatments specifically tailored to the genetic profile of their disease, significantly increasing their survival chances and paving the way for a new era of precision medicine. Exercise slashes the risk of death in cancer patients by more than a third, a landmark trial found. Physical activity could also prevent the disease coming back and stop new tumours developing, as well as lifting mood, reducing fatigue and boosting strength. The world's first randomised clinical trial to specifically evaluate if a structured exercise regime after treatment could reduce the risk of recurrence or new cancers in patients took place over more than a decade. Hailed as gamechanging by experts, the results show it could. The trial found patients had a 37% lower risk of death and a 28% lower risk of their cancer coming back or new cancers developing, compared with patients who received only health advice. 'When we saw the results, we were just astounded,' said the study's lead author, Dr Christopher Booth, of Queen's University in Kingston, Canada. Margaret Tubridy was one of 889 patients with colon cancer recruited to the trial from six countries – the UK, US, Australia, France, Canada and Israel. Five years after her diagnosis, she told the Guardian she was now free of cancer and healthy, with no signs of the disease coming back. Amid a series of breakthroughs aimed at tackling the most common cancer in women, doctors were told a new drug can stop some breast cancer tumours before they grow. A trial showed that camizestrant stops cancer cells from using hormones to grow, which helps patients stay well longer and delays the need for chemotherapy. It was the first global study to show that using blood tests to find early signs of cancer resistance to treatment helps patients. The study looked at patients who had hormone-positive, HER2-negative breast cancer, which is about 70% of cases. Results showed patients given camizestrant reduced their chances of cancer progression by 56%, compared with standard therapies. 'This is going to be very impactful for our patients,' said Dr Hope Rugo, the head of breast medical oncology at City of Hope hospital in Duarte, California. A second trial found that a new triple therapy for aggressive, advanced breast cancer slows the progression of the disease, delays the need for further chemotherapy and helps patients live longer. Artificial intelligence could help end a 'postcode lottery' for a life-extending treatment for prostate cancer, researchers said. Abiraterone is a hormone therapy described as a 'gamechanger' that works by blocking the production of testosterone, which fuels prostate cancer growth. It has already helped hundreds of thousands with advanced prostate cancer to live longer. But some countries, including England, have stopped short of offering the 'spectacular' drug more widely to men whose disease has not spread. A team from the US, UK and Switzerland have built an AI test that shows which men would most likely benefit from abiraterone. The breakthrough will enable healthcare systems to roll out the drug to more men, and spare others unnecessary treatment.


Daily Mail
an hour ago
- Daily Mail
Family member of Mary Lou Retton makes alarming claim about her health after DUI arrest
Mary Lou Retton is still unable to draw a full breath and only needs one drink to 'throw off her brain chemistry', her ex-brother-in-law has revealed after her recent DUI arrest. The 57-year-old Olympic legend, who overcame a near-fatal illness back in 2023, was arrested on May 17 in Marion County for 'driving under influence of alcohol, controlled substances, or drugs' before being released after personally posting a $1,500 bond. Just over a year since a rare form of pneumonia left her fighting for her life in a hospital ICU, news of Retton's booze-fueled antics sparked concern as she continues to undergo treatment for long Covid and lung problems. And according to Shaun Kelley, the brother of her ex-husband Shannon, just one drink is capable of causing a chemical imbalance in Mary Lou's brain because of the medications she's currently taking. 'She couldn't even take a full breath when I talked to her, she takes these little panting breaths,' Shaun told The New York Post about his ex-sister-in-law, whom he says has no history of alcohol abuse. He also added: 'She is on all these meds and one drink could throw off her brain chemistry. Retton, who is said to be 'healing' well and laying low in West Virginia since the arrest, came under fire in the wake of her pneumonia battle over $500,000 worth of charity donations made to help fund her medical bills. After her four daughters - whom she shares with Shannon - set up a crowdfunding page, the family soon drew criticism after refusing to clarify where the donations would be going. Retton's claim to not have insurance was also doubted by some. But seven years on from her divorce from his brother, Shaun said: 'She's a great mother and a giving person, she raised four amazing daughters,' before adding that he hopes she gets better. While there was a happy ending for her in 2023, doctors briefly feared for Retton's life as her daughters delivered what they thought would be their final farewell to their mother. Even now, the former gymnast fears she will never properly recover from the damage to her lungs. 'It's been really hard,' she said in an emotional interview with People in 2024. 'My lungs are so scarred. It will be a lifetime of recovery. 'My physicality was the only thing I had and it was taken away from me. It's embarrassing.' Retton believes she recovered from the terrifying ordeal as 'God wasn't ready' for her yet, despite admitting that she is extremely fortunate to still be alive. 'Girl, I should be dead,' she added. 'The doctors told them [daughters] to come to say their goodbyes. 'They prayed over me, and McKenna said, 'Mommy, it's OK, you can go.' 'I didn't have much of a relationship with my mother, but I can't imagine what that was like, to watch their mom on her deathbed.'


North Wales Chronicle
an hour ago
- North Wales Chronicle
Alzheimer's blood test ‘can accurately pick up early symptoms'
Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia, by examining two proteins in blood plasma. These proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque build-up, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. He added: 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US – we hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40, and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. 'The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'